ANNEXON, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANNEXON, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $487.00K, a 167.58% increase year-over-year.
- ANNEXON, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $182.00K, a 15.35% decline year-over-year.
- ANNEXON, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $215.00K, a 37.68% decline year-over-year.
- ANNEXON, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $345.00K, a 205.31% increase year-over-year.
- ANNEXON, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $454.00K, a 25.41% increase from fiscal 2024.
- ANNEXON, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $362.00K, a 24.43% decline from fiscal 2023.
- ANNEXON, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $479.00K, a 40.88% increase from fiscal 2022.
- ANNEXON, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $340.00K, a 83.78% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $487.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $454.00K 10-K · filed 2026-03-30 | |
| 2025-06-30 | $182.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $362.00K 10-K · filed 2026-03-30 | |
| 2024-06-30 | $215.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $479.00K 10-K · filed 2025-03-03 | |
| 2023-06-30 | $345.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $340.00K 10-K · filed 2024-03-26 | |
| 2022-06-30 | $113.00K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $185.00K 10-K · filed 2023-03-06 | |
| 2021-06-30 | $118.00K 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |